TransCode Therapeutics, Inc. Common Stock (RNAZ) is a publicly traded Healthcare sector company. As of October 26, 2026, RNAZ trades at $1.74 with a market cap of $29.97M and a P/E ratio of -0.03. RNAZ moved +0.00% today. Year to date, RNAZ is -72.52%; over the trailing twelve months it is -88.01%. Its 52-week range spans $1.52 to $61.60. Rallies surfaces RNAZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks RNAZ insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.74 |
| Market Cap | $29.97M |
| P/E Ratio | -0.03 |
| EPS | $-52.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $61.60 |
| 52-Week Low | $1.52 |
| Volume | 21.58K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-34.66M |
| Gross Margin | 0.00% |
RNAZ analyst coverage data. Average price target: $0.00.